The estimated Net Worth of William Benton Jones is at least $703 ezer dollars as of 6 May 2024. William Jones owns over 20,000 units of Corvus Pharmaceuticals Inc stock worth over $702,743 and over the last 9 years he sold CRVS stock worth over $0. In addition, he makes $0 as Senior Vice President of Pharmaceutical Development at Corvus Pharmaceuticals Inc.
Sign up
William Jones CRVS stock SEC Form 4 insiders trading
William has made over 2 trades of the Corvus Pharmaceuticals Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 20,000 units of CRVS stock worth $34,600 on 6 May 2024.
The largest trade he's ever made was buying 20,000 units of Corvus Pharmaceuticals Inc stock on 6 May 2024 worth over $34,600. On average, William trades about 3,333 units every 42 days since 2016. As of 6 May 2024 he still owns at least 153,773 units of Corvus Pharmaceuticals Inc stock.
You can see the complete history of William Jones stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
William Jones biography
Dr. William Benton Jones Ph.D. serves as Senior Vice President of Pharmaceutical Development of the Company. Dr. Jones was Director of Global Regulatory Affairs in the oncology business unit of Sanofi US, LLC, a pharmaceutical company, from December 2012 to December 2014. From 2008 to March 2012, Dr. Jones was Director of Project Management & Regulatory at Pharmacyclics, Inc., a biopharmaceutical company. Dr. Jones served as Associate Director of Development for Plexxikon, Inc., a pharmaceutical company, from 2005 to 2007. From 2002 to 2005, he was Senior Project Manager at Vertex Pharmaceuticals, Inc., a biotechnology company. Dr. Jones received a B.S. and a Ph.D. in Chemistry from the University of Cincinnati and an M.B.A. from Babson College. He completed a post-doctoral fellowship at the University of Oxford.
How old is William Jones?
William Jones is 55, he's been the Senior Vice President of Pharmaceutical Development of Corvus Pharmaceuticals Inc since 2014. There are 12 older and 5 younger executives at Corvus Pharmaceuticals Inc. The oldest executive at Corvus Pharmaceuticals Inc is Dr. Richard A. Miller M.D., 70, who is the Co-Founder, Pres, CEO & Chairman.
What's William Jones's mailing address?
William's mailing address filed with the SEC is C/O CORVUS PHARMACEUTICALS, INC., 863 MITTEN ROAD, SUITE 102, BURLINGAME, CA, 94010.
Insiders trading at Corvus Pharmaceuticals Inc
Over the last 9 years, insiders at Corvus Pharmaceuticals Inc have traded over $52,808,904 worth of Corvus Pharmaceuticals Inc stock and bought 11,523,300 units worth $85,214,510 . The most active insiders traders include Holdings A/S Novo, Street Partners Llc Adams és Capital, Llc Eco R1. On average, Corvus Pharmaceuticals Inc executives and independent directors trade stock every 46 days with the average trade being worth of $1,530,854. The most recent stock trade was executed by William Benton Jones on 6 May 2024, trading 20,000 units of CRVS stock currently worth $34,600.
What does Corvus Pharmaceuticals Inc do?
corvus pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. with accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology.
What does Corvus Pharmaceuticals Inc's logo look like?
Complete history of William Jones stock trades at Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc executives and stock owners
Corvus Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Daniel Hunt,
Senior Vice President, Chief Business Officer -
Mehrdad Mobasher,
Vice President, Chief Medical Officer -
Richard Miller,
Chairman of the Board, President, Chief Executive Officer -
Leiv Lea,
Chief Financial Officer -
Dr. Mehrdad Mobasher M.D., M.P.H.,
Sr. VP & Chief Medical Officer -
Leiv Lea,
Chief Financial Officer -
Steve Krognes,
Independent Director -
Peter Thompson,
Independent Director -
Elisha Gould,
Independent Director -
Dr. Richard A. Miller M.D.,
Co-Founder, Pres, CEO & Chairman -
Scott Morrison,
Independent Director -
Dr. Peter A. Thompson FACP, M.D.,
Co-Founder & Independent Director -
Linda Grais,
Independent Director -
Ian Clark,
Independent Director -
Edith Mitchell,
Director -
Erik Verner,
Vice President of Chemistry Research -
William Jones,
Senior Vice President of Pharmaceutical Development -
Dr. James T. Rosenbaum M.D.,
Sr. VP of Research -
Dr. Erik J. Verner Ph.D.,
Co-Founder -
Stephen Willingham,
Sr. Scientist -
Alan C. Mendelson Esq.,
Sec. -
Dr. Long Kwei Ph.D.,
Sr. VP of Biometrics -
Dr. William Benton Jones,
Sr. VP of Pharmaceutical Devel. -
Debra Horen SPHR,
VP of HR -
Street Partners Llc Adams,
10% owner -
Advisors Llc Orbi Med Capit...,
-
Jason V Coloma,
SVP, Chief Business Officer -
Holdings A/S Novo,
10% owner -
Advisors Llc Orbimed,
Director -
Terry P Gould,
-
Joseph J Buggy,
EVP, Discovery Research -
Advisors Llc Orbi Med Capit...,
-
Capital, Llc Eco R1,
10% owner -
Jeffrey Arcara,
Chief Business Officer